Good morning all
For those with an interest in the B cell platform, an interesting journal article is now out in the journal "Frontiers In Immunology."
It's a pretty comprehensive overview of current Immunology treatments for Gastric Cancer - those in the market and those under development.
Her-vaxx gets positive coverage on page 11.
https://www.researchgate.net/publication/389847297_HER2-positive_gastric_cancer_from_targeted_therapy_to_CAR-T_cell_therapy
Meanwhile, Prof Kaumaya is presenting on PD1-vaxx and his other B cell vaccines at the World Vaccine Congress on 23 April.
https://www.terrapinn.com/conference/world-vaccine-congress-washington/speaker-pravin-KAUMAYA.stm
As friend @Steini reported back on 28 Feb, the NEO-Polem trial of PD1-vaxx is starting in the UK around now. https://hotcopper.com.au/threads/ann-half-yearly-report-and-accounts.8471016/page-2?post_id=78072188
For more info on that trial: https://www.southampton.ac.uk/ctu/trialportfolio/listoftrials/neopolem.page
Cheers
Dave
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $82.13M | |||
| Open | High | Low | Value | Volume |
| 1.1¢ | 1.2¢ | 1.1¢ | $338.0K | 30.69M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 3480808 | 1.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.2¢ | 10994115 | 28 |
View Market Depth
| Last trade - 16.10pm 26/06/2025 (20 minute delay) ? |
| IMU (ASX) Chart |